X4 Pharmaceuticals Inc
Company Profile
Business description
X4 Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company engaged in the research and development of novel therapeutics for the treatment of rare diseases and those with limited treatment options, with a focus on conditions resulting from dysfunction of the immune system. The Company’s lead clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It has the ability to increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.
Contact
61 North Beacon Street
4th Floor
Boston MA 02134
USAT: +1 857 529-8300
E: Candice.ellis@x4pharma.com
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2024
Employees
93
Stocks News & Analysis
stocks
Going into earnings, Is Facebook parent Meta a buy, a sell, or fairly valued?
stocks
2 ASX shares to avoid
stocks
Is this ASX miner a bargain after shares plunge?
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
---|---|---|---|
All Ordinaries | 8,205.50 | 3.10 | -0.04% |
CAC 40 | 7,513.73 | 84.90 | -1.12% |
DAX 40 | 18,387.46 | 170.24 | -0.92% |
Dow JONES (US) | 40,002.37 | 355.72 | -0.88% |
FTSE 100 | 8,153.69 | 13.68 | -0.17% |
HKSE | 17,311.05 | 158.31 | -0.91% |
NASDAQ | 17,455.25 | 542.11 | -3.01% |
Nikkei 225 | 39,154.85 | 439.54 | -1.11% |
NZX 50 Index | 12,530.99 | 105.41 | 0.85% |
S&P 500 | 5,454.37 | 101.37 | -1.82% |
S&P/ASX 200 | 7,963.70 | 7.40 | -0.09% |
SSE Composite Index | 2,901.95 | 13.42 | -0.46% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
---|---|---|---|
Argosy Minerals Ltd AGY | 0.05 | 0.03 | -39.51% |
Pilbara Minerals Ltd PLS | 2.89 | 0.00 | 0.00% |
Sayona Mining Ltd SYA | 0.03 | 0.00 | -3.03% |
Droneshield Ltd DRO | 1.48 | 0.06 | 3.87% |
Imugene Ltd IMU | 0.06 | 0.00 | -6.67% |
Core Lithium Ltd CXO | 0.09 | 0.00 | -4.08% |
South32 Ltd S32 | 2.96 | 0.02 | -0.67% |
Zip Co Ltd ZIP | 1.83 | 0.03 | 1.39% |
Red 5 Ltd RED | 0.42 | 0.03 | 6.41% |
Worley Ltd WOR | 15.23 | 0.04 | 0.26% |